343 related articles for article (PubMed ID: 10980415)
41. Dimerization of SOX9 is required for chondrogenesis, but not for sex determination.
Bernard P; Tang P; Liu S; Dewing P; Harley VR; Vilain E
Hum Mol Genet; 2003 Jul; 12(14):1755-65. PubMed ID: 12837698
[TBL] [Abstract][Full Text] [Related]
42. Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9.
Tsuda M; Takahashi S; Takahashi Y; Asahara H
J Biol Chem; 2003 Jul; 278(29):27224-9. PubMed ID: 12732631
[TBL] [Abstract][Full Text] [Related]
43. Loss of Sox9 function results in defective chondrocyte differentiation of mouse embryonic stem cells in vitro.
Hargus G; Kist R; Kramer J; Gerstel D; Neitz A; Scherer G; Rohwedel J
Int J Dev Biol; 2008; 52(4):323-32. PubMed ID: 18415932
[TBL] [Abstract][Full Text] [Related]
44. Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription.
Amano K; Hata K; Muramatsu S; Wakabayashi M; Takigawa Y; Ono K; Nakanishi M; Takashima R; Kogo M; Matsuda A; Nishimura R; Yoneda T
Mol Biol Cell; 2011 Apr; 22(8):1300-11. PubMed ID: 21346191
[TBL] [Abstract][Full Text] [Related]
45. L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity.
Yamashita S; Miyaki S; Kato Y; Yokoyama S; Sato T; Barrionuevo F; Akiyama H; Scherer G; Takada S; Asahara H
J Biol Chem; 2012 Jun; 287(26):22206-15. PubMed ID: 22547066
[TBL] [Abstract][Full Text] [Related]
46. Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene.
Rentsendorj O; Nagy A; Sinkó I; Daraba A; Barta E; Kiss I
Biochem J; 2005 Aug; 389(Pt 3):705-16. PubMed ID: 15804237
[TBL] [Abstract][Full Text] [Related]
47. S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes.
Saito T; Ikeda T; Nakamura K; Chung UI; Kawaguchi H
EMBO Rep; 2007 May; 8(5):504-9. PubMed ID: 17396138
[TBL] [Abstract][Full Text] [Related]
48. Brief report: importance of SOX8 for in vitro chondrogenic differentiation of human mesenchymal stromal cells.
Herlofsen SR; Høiby T; Cacchiarelli D; Zhang X; Mikkelsen TS; Brinchmann JE
Stem Cells; 2014 Jun; 32(6):1629-35. PubMed ID: 24449344
[TBL] [Abstract][Full Text] [Related]
49. Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line.
Locker M; Kellermann O; Boucquey M; Khun H; Huerre M; Poliard A
J Bone Miner Res; 2004 Jan; 19(1):100-10. PubMed ID: 14753742
[TBL] [Abstract][Full Text] [Related]
50. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.
Osaki M; Tan L; Choy BK; Yoshida Y; Cheah KS; Auron PE; Goldring MB
Biochem J; 2003 Jan; 369(Pt 1):103-15. PubMed ID: 12223098
[TBL] [Abstract][Full Text] [Related]
51. The transcription factor Znf219 regulates chondrocyte differentiation by assembling a transcription factory with Sox9.
Takigawa Y; Hata K; Muramatsu S; Amano K; Ono K; Wakabayashi M; Matsuda A; Takada K; Nishimura R; Yoneda T
J Cell Sci; 2010 Nov; 123(Pt 21):3780-8. PubMed ID: 20940257
[TBL] [Abstract][Full Text] [Related]
52. Oligonucleotide decoy mimicking alphaA-crystallin-binding protein 1 binding site on mouse Col2a1 enhancer stimulates transcription from the adjacent Col2a1 promoter in chondrogenic ATDC5 cell.
Yamagiwa H; Yamada Y; Bolander ME; Sarkar G
Mol Biotechnol; 2004 Sep; 28(1):1-8. PubMed ID: 15456958
[TBL] [Abstract][Full Text] [Related]
53. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9.
Xie WF; Zhang X; Sakano S; Lefebvre V; Sandell LJ
J Bone Miner Res; 1999 May; 14(5):757-63. PubMed ID: 10320524
[TBL] [Abstract][Full Text] [Related]
54. Toward understanding SOX9 function in chondrocyte differentiation.
Lefebvre V; de Crombrugghe B
Matrix Biol; 1998 Mar; 16(9):529-40. PubMed ID: 9569122
[TBL] [Abstract][Full Text] [Related]
55. Interactions between Sox9 and beta-catenin control chondrocyte differentiation.
Akiyama H; Lyons JP; Mori-Akiyama Y; Yang X; Zhang R; Zhang Z; Deng JM; Taketo MM; Nakamura T; Behringer RR; McCrea PD; de Crombrugghe B
Genes Dev; 2004 May; 18(9):1072-87. PubMed ID: 15132997
[TBL] [Abstract][Full Text] [Related]
56. Sox9 expression during chondrogenesis in micromass cultures of embryonic limb mesenchyme.
Kulyk WM; Franklin JL; Hoffman LM
Exp Cell Res; 2000 Mar; 255(2):327-32. PubMed ID: 10694448
[TBL] [Abstract][Full Text] [Related]
57. Mechanism of regulatory target selection by the SOX high-mobility-group domain proteins as revealed by comparison of SOX1/2/3 and SOX9.
Kamachi Y; Cheah KS; Kondoh H
Mol Cell Biol; 1999 Jan; 19(1):107-20. PubMed ID: 9858536
[TBL] [Abstract][Full Text] [Related]
58. Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway.
Yagi R; McBurney D; Horton WE
J Biol Chem; 2005 Aug; 280(34):30517-25. PubMed ID: 15975921
[TBL] [Abstract][Full Text] [Related]
59. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage.
Ikeda T; Kamekura S; Mabuchi A; Kou I; Seki S; Takato T; Nakamura K; Kawaguchi H; Ikegawa S; Chung UI
Arthritis Rheum; 2004 Nov; 50(11):3561-73. PubMed ID: 15529345
[TBL] [Abstract][Full Text] [Related]
60. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes.
Aigner T; Gebhard PM; Schmid E; Bau B; Harley V; Pöschl E
Matrix Biol; 2003 Jun; 22(4):363-72. PubMed ID: 12935820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
